Search Results 791-800 of 18922 for creatine

1. A Study to Evaluate MUC1 Vaccine to Prevent Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer - Mayo Clinic

   ... Creatinine =< institutional upper limit of normal (ULN) Exclusion Criteria: - PRE-REGISTRATION EXCLUSION CRITERIA - History of any malignancy; exceptions ...

2. A Trial of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS (RAVENS) - Mayo Clinic

   Serum creatinine > 3 times the upper limit of normal. Total bilirubin > 3 times the upper limit of normal. Liver Transaminases > 5-times the upper limit of ...

3. A Study Evaluating Temozolomide vs. Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma - Mayo Clinic

   Creatinine < 1.5 x ULN OR Calc. Creatinine Clearance > 50 mL/min.***. *. In the absence of transfusion within the previous 24 hours. ** Except in the case of ...

4. Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) - Mayo Clinic

   Renal insufficiency (creatinine > 1.5); Diabetes; Medications that can significantly affect endothelial function; Pregnancy; Breast Feeding; Taking oral ...

5. Study of Adjuvant Regorafenib vs Placebo in Patients with Node Positive Esophageal Cancer who Completed Pre-operative Therapy - Mayo Clinic

   Serum creatinine ≤ 1.5 x the ULN; INR/PTT ≤1.5xULN. Note-Subjects who are therapeutically treated with an agent such as warfarin or heparin will be allowed ...

6. A Study in Treating Patients With Kidney Cancer Undergoing Nephrectomy Comparing PERioperative Nivolumab vs. Observation - Mayo Clinic

   Serum creatinine =< 1.5 x upper limit of normal (ULN) or calculated creatinine clearance (CrCl) >= 40 mL/min, within 4 weeks of randomization. Total ...

7. A Study to Evaluate Genetic Testing in Guiding Treatment for Patients with Brain Metastases - Mayo Clinic

   Creatinine ≤ 1.5 mg/dL OR calculated (Calc.) creatinine clearance > 45 mL/min. No uncontrolled medical comorbidities per investigator discretion (e.g. ...

8. Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) - Mayo Clinic

   Serum creatinine ≤ 2.0 × ULN; OR; Creatinine clearance > 40 mL/min based on the Cockcroft-Gault glomerular filtration rate estimation: (140 – Age) × (Weight ...

9. A Study Comparing Combination Chemotherapy to Gemcitabine Hydrochloride and Nab-Paclitaxel Given Before Surgery for Treating Patients who have Pancreatic Cancer that can be Removed by Surgery - Mayo Clinic

   Serum creatinine ≤ IULN within 14 days prior to registration; Sites must seek additional patient consent for the future use of specimens; Must be informed of ...

10. Combining Immunotherapy And Radiation Therapy To Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial - Mayo Clinic

    ... creatinine clearance ≥ 40 mL/min using the following Cockcroft-Gault Formula. This specimen must have been drawn and processed within 3 days prior to ...